Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Jan 19;169(1):47–57. doi: 10.1007/s10549-017-4649-y

Table 1.

Primers used for qRT-PCR analyses

Gene Forward primer Reverse primer
hPCNA 5′- GTCTCTTTGGTGCAGCTCA -3′ 5′- ATCTTCGGCCCTTAGTGTAATG -3′
hFABP4 5′- CATGTGCAGAAATGGGATGG -3′ 5′- AACTTCAGTCCAGGTCAACG -3′
hPDK4 5′- TGAGACTCGCCAACATTCTG -3′ 5′- TCTGGTCATCTGGGCTTTTC -3′
hPLIN2 5′- GCTCCATTCTACTGTTCACCTG -3′ 5′- CTCCTTTTCCACTCTACCCATG -3′
hMUC1 5′- TCCTCACAGTGCTTACAGTTG -3′ 5′- AGAAAGAGACCCCAGTAGACA -3′
hCK8 5′- AAGGCACAGTACGAGGATATTG -3′ 5′- AGATCTCAGTCTTTGTGCGC -3′
hESR1 5′- ATCTCGGTTCCGCATGATGAATCTGC -3′ 5′- TGCTGGACAGAAATGTGTACACTCCAGA -3′
hPgR 5′- ATTACCAGTGTTCCCGTCTTC -3′ 5′- GTGCTCCAATAGTTCCCTGTAC -3′
hCK6a 5′- TCCCCTCAACCTGCAAATC -3′ 5′- CCACTTTGTTTCCAGAACCTTG -3′
hCK6b 5′- AGCTGAGAAACATGCAGGAC -3′ 5′- GCTTGCAGTTCAACCTTGTTC -3′
hCK17 5′- AACAAGATCCTCACAGCCAC -3′ 5′- CCATTGATGTCGGCCTCC -3′
hGAPDH 5′- CCCACATGGCCTCCAAGGAGTA -3′ 5′- GTCTACATGGCAACTGTGAGGAGG -3′
hβ2m 5′- CTTAGCTGTGCTCGCGCTACTCT -3′ 5′- CCATTCTCTGCTGGATGACGTGAGT -3′
mFABP4 5′- GACAGGAAGGTGAAGAGCATC -3′ 5′- GTCACGCCTTTCATAACACATTC -3′
mPDK4 5′- AGTGACTCAAAGACGGGAAAC -3′ 5′- GTGTGAGGTTTAATTCTGGCG -3′
mPLIN2 5′- GGATAAGCTCTATGTCTCGTGG -3′ 5′- GTCTGGCATGTAGTCTGGAG -3′
mCK8 5′- TGTTGAGCCCCTTGAAGC -3′ 5′- GGTCTCCAGCATCTTGTTCTG -3′
m CK18 5′- ACACCAACATCACAAGGCTG -3′ 5′- TTCCACAGTCAATCCAGAGC -3′
mESR1 5′- AACCGCCCATGATCTATTCTG -3′ 5′- AGATTCAAGTCCCCAAAGCC -3′
mPgR 5′- TGAGCCTGATGGTGTTTGG -3′ 5′- ACAGCGAGTAGAATGACAGC -3′
mACTIN 5′- ATTTCTGAATGGCCCAGGTC -3′ 5′- GCTGCCTCAACACCTCAA -3′

MUC1 mucin 1, CK cytokeratin, ESR1 estrogen receptor 1, PgR progesterone receptor, β2m β2-microglobulin